144 related articles for article (PubMed ID: 24844960)
1. [Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma].
Tian L; Zhang C; Liu W; Wang X; Zheng W; Xie Y; Lin N; Ying Z; Ping L; Deng L; Song Y; Zhu J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):759-62. PubMed ID: 24844960
[TBL] [Abstract][Full Text] [Related]
2. [The clinical characteristics and prognostic analysis of gastric mucosa-associated lymphoid tissue lymphoma of 103 cases].
Li XW; Xia B; Guo Q; Jin X; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):805-9. PubMed ID: 23384898
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma.
Xu X; Wang Z; Yu Y; Wang Y; Zhang L; Sun B; Da W; Zhang Y
J Gastroenterol Hepatol; 2014 Sep; 29(9):1678-84. PubMed ID: 24730769
[TBL] [Abstract][Full Text] [Related]
5. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
[TBL] [Abstract][Full Text] [Related]
6. [Analyses of clinical features and outcomes of 57 patients with non-gastric MALT lymphoma].
Zhang L; Chang C; Wang QS; Zhao Y; Zhu HY; Jing Y; Huang WR; Bo J; Han XP; Li HH; Yu L; Gao CJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):225-8. PubMed ID: 23683421
[TBL] [Abstract][Full Text] [Related]
7. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
10. Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.
Ueda K; Terui Y; Yokoyama M; Sakajiri S; Nishimura N; Tsuyama N; Takeuchi K; Hatake K
Leuk Lymphoma; 2013 Sep; 54(9):1928-33. PubMed ID: 23216271
[TBL] [Abstract][Full Text] [Related]
11. Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Papaxoinis G; Fountzilas G; Rontogianni D; Dimopoulos MA; Pavlidis N; Tsatalas C; Pectasides D; Xiros N; Economopoulos T
Ann Oncol; 2008 Apr; 19(4):780-6. PubMed ID: 18156143
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment risk factors for overall survival in patients with gastrointestinal and non-gastrointestinal mucosa associated lymphoid tissue lymphomas.
Virijevic M; Perunicic-Jovanovic M; Djunic I; Novkovic A; Mihaljevic B
J BUON; 2014; 19(1):178-82. PubMed ID: 24659661
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer.
Ono S; Kato M; Takagi K; Kodaira J; Kubota K; Matsuno Y; Komatsu Y; Asaka M
J Gastroenterol Hepatol; 2010 Apr; 25(4):804-9. PubMed ID: 20492338
[TBL] [Abstract][Full Text] [Related]
16. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).
Jackson AE; Mian M; Kalpadakis C; Pangalis GA; Stathis A; Porro E; Conconi A; Cortelazzo S; Gaidano G; Lopez Guillermo A; Johnson PW; Martelli M; Martinelli G; Thieblemont C; McPhail ED; Copie-Bergman C; Pileri SA; Jack A; Campo E; Mazzucchelli L; Ristow K; Habermann TM; Cavalli F; Nowakowski GS; Zucca E
Oncologist; 2015 Oct; 20(10):1149-53. PubMed ID: 26268740
[TBL] [Abstract][Full Text] [Related]
17. [Non-gastric mucosa-associated lymphoid tissue (MALT) lymphomas: analysis of 14 patients].
Ferrer A; López-Guillermo A; Bosch F; Montoto S; Hernández-Boluda JC; Camós M; Miquel R; Campo E; Montserrat E
Med Clin (Barc); 1999 May; 112(15):577-80. PubMed ID: 10365385
[TBL] [Abstract][Full Text] [Related]
18. Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Suh C; Kim HJ
Cancer Sci; 2010 Nov; 101(11):2443-7. PubMed ID: 20831770
[TBL] [Abstract][Full Text] [Related]
19. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
20. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]